Renflexis 100 MG vials
Ended Awarded
- Contract number
- SPE2DX25F6VDL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $14,779
Award facts
- Contract value 100% obligated
- $14,778.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Renflexis 100 mg vials with a ceiling value of $14,778.74. This firm fixed-price delivery order, which is set to be completed by September 18, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. Renflexis is a biosimilar medication used in treating inflammatory conditions, and this procurement is part of the Defense Health Agency's ongoing efforts to maintain critical pharmaceutical supplies for military and veteran healthcare systems.
AmerisourceBergen Drug Corp was selected through competitive procurement without set-aside restrictions, consistent with its established track record of delivering federal medical supplies. The company's $999.999 billion indefinite delivery contract with DLA Troop Support Medical, which runs through December 2026, provides the overarching vehicle for this and similar pharmaceutical delivery orders across multiple therapeutic domains. This delivery order demonstrates the company's central role in the federal pharmaceutical supply chain, particularly in supporting military healthcare operations requiring both brand-name and generic medications, vaccines, and specialized medical commodities.
Quick answers
Who was awarded contract SPE2DX25F6VDL?
SPE2DX25F6VDL was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on September 17, 2025.
How much is contract SPE2DX25F6VDL worth?
The government has obligated $14,779 on SPE2DX25F6VDL.
Is contract SPE2DX25F6VDL an order under another contract?
Yes. SPE2DX25F6VDL is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6VDL competed?
The extent of competition for SPE2DX25F6VDL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award